Skip to main content
. 2024 Apr 8;3(2):e115. doi: 10.1002/cai2.115

Figure 5.

Figure 5

Mechanism of rituximab via binding to B cells, cause breakage; and complete depletion of B cells, rituximab diverts monocytes or macrophages from binding with tissue‐associated immune complexes [65], adopted with permission. ADCC, antibody‐dependent cellular cytotoxicity; CR, complement receptor; NK, natural killer.